GMP CELL THERAPY CONSUMABLES MARKET SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2024-2031)

GMP Cell Therapy Consumables Market Size and Trends

Global GMP cell therapy consumables market is estimated to be valued at USD 14.04 Mn in 2024 and is expected to reach USD 80.03 Mn by 2031, exhibiting a compound annual growth rate (CAGR) of 28.2% from 2024 to 2031. Growing cell therapy industry and increasing investments in cellular research can boost demand for GMP-compliant products needed in cell therapy manufacturing.

To learn more about this report, request sample copy

Market Driver - Increasing investment in cell-based research

Global GMP cell therapy consumables market growth is driven by rising investments directed towards cell-based research activities. Several biotech and pharmaceutical companies have increased their R&D spending on developing novel cell-based therapies as a treatment option for a wide range of medical conditions. Growth in stem cell research and regenerative medicines have also boosted investments from both private as well as public sectors.

Many market leaders in the consumables space have expanded their product portfolio as well as production facilities to cater to demands arising from cell therapy clinical trials and research projects. This is evident from rising number of collaborations between consumable suppliers and cell therapy developers. Furthermore, government initiatives aimed at providing funding and policy support for cell-based research projects have created a favorable environment for commercialization of new therapeutic applications. Regulatory approvals for advanced therapy medicinal products lead to increase in clinical research in this domain.

Research institutes and academic organizations have also increased their funding on cell-based studies related to cancer immunology, neurodegenerative disorders, genetic diseases, and others. Current pandemic situation has also boosted investments towards development of vaccine candidates based on cell culture processing. All these factors have collectively boosted demand for high-quality and GMP compliant consumables from cell therapy researchers. With greater participation from both public and private players, investments can drive the market growth.

Rising incidence of cancer and other infectious diseases

Rising prevalence of chronic medical conditions like cancer and infectious diseases can drive the global GMP cell therapy consumables market growth. According to recent statistics, cancer cases worldwide have increased in last few decades with breast, lung and colorectal cancers topping the charts. Developing nations have observed increase due to lifestyle changes and environmental factors. The economic burden of cancer on healthcare systems worldwide have escalated the need for newer treatment approaches like cell therapies.

Viral diseases such as HIV/AIDS, hepatitis, influenza, and others impact millions globally. Outbreaks of infectious illnesses including swine flu, zika virus and most recently coronavirus further highlight the urgent need for advanced therapies. Cell culture consumables have wide application from vaccine development and testing to production of therapeutic cells for these conditions. Their growth inhibiting properties, controlled environment and sterility assurance are indispensable in manufacturing cell-based products. With rising R&D for cell therapeutics, there has been huge demand for associated GMP-enabled consumables from academic as well as commercial end users.